This clinical trial is designed to test a new treatment for diabetes. The goal is to determine its effectiveness and safety for patients. Participants will be monitored closely by healthcare professionals throughout the study.
- Who Can Participate: Individuals aged 18-65 with a diagnosis of type 2 diabetes
- Study Details: The trial will last for 12 months, during which participants will receive the study medication and attend regular health check-ups
- Study Timelines and Visits: The study is expected to begin in January 2024 and conclude by December 2024.Participants are required to visit the clinic once a month for assessments
How understandable was the trial content above?
Hard to understand
Easy to understand